Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder CancerBusiness Wire • 09/22/26
Natera, Inc. (NTRA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/20/26
Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTMBusiness Wire • 09/18/26
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters.The Motley Fool • 09/14/26
Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia)The Motley Fool • 09/08/26
New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in LymphomaBusiness Wire • 09/01/26
Natera & Angiex Partner to Evaluate AGX101 Response With SignateraZacks Investment Research • 08/28/26
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast CancerBusiness Wire • 08/28/26
Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™Business Wire • 08/27/26
Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story?The Motley Fool • 08/20/26
Natera Supports Kupando Trial to Advance ctDNA Monitoring in CancerZacks Investment Research • 08/17/26
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord ConferenceMarketBeat • 08/15/26
Natera, Inc. (NTRA) Presents at Canaccord Genuity's 46th Annual Growth Conference TranscriptSeeking Alpha • 08/13/26
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin CancersBusiness Wire • 08/12/26
Natera Shares Soar Over 20% To All-Time High, Bolstering Co-Founder's Billionaire StatusForbes • 08/07/26
Natera Eyes Massive New Cancer Market; In Buy Zone With Q2 Report DueInvestors Business Daily • 08/06/26
Natera Submits Signatera™ to Japan's PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder CancerBusiness Wire • 08/05/26